2
h-index
2
Publications
3,244
Citations

Publications

2 shown

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Harold J. Burstein , Lyndsay N. Harris , P. Kelly Marcom +15 more

Purpose: Trastuzumab-based therapy improves survival for women with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. We conducted a multicenter p...

2003 Journal of Clinical Oncology 343 citations

Frequent Co-Authors

Researcher Info

h-index
2
Publications
2
Citations
3,244
Institution
Dana-Farber Cancer Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID
0000-0002-0552-1644

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.